Medical devices, healthcare technology and the business of care
PMA approval · P860004

MEDTRONIC(R) SYNCHROMED(TM) PUMP & INFUSION SYSTEM

Medtronic, Inc. · Decision date Mar 14, 1988

FDA DECISIONP860004

What did the FDA approve?

FDA records P860004 as an original PMA application. The recorded decision is approval, dated Mar 14, 1988.

FDA approval order statement

Approval for the Medtronic SynchroMed Infusion System. This device is indicated for chronic intravascular infusion of floxuridine (FUDR) or doxorubicin hydrochloride (Adriamycin) and, when required bacteriostatic water, physiological saline and/or heparin.
Regulatory pathway
Original PMA
Clinical specialty
General Hospital
Decision date
Mar 14, 1988

FDA source record

Regulatory record facts

Identifier
P860004
Regulatory pathway
Premarket approval application
Product code
LKK
Decision code
APPR
Decision date
Mar 14, 1988
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Pump, infusion, implanted, programmable.

Product code
LKK
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P860004 received

    Application receipt date recorded by FDA.

  2. P860004 · FDA decision

    APPR

  3. P860004/S462 · Related supplement

    SynchroMed Infusion System, Ascenda Intrathecal Catheters

  4. P860004/S458 · Related supplement

    SynchroMed Infusion System, Ascenda Intrathecal Catheters

  5. P860004/S464 · Related supplement

    SynchroMed Infusion System, Ascenda Intrathecal Catheters TDD (Drug Delivery Infusion Pump 8667), TDD (Drug Delivery I

  6. P860004/S465 · Related supplement

    SynchroMed Infusion System, Ascenda Intrathecal Catheters

Timeline entries are records held by MedtechLedger for P860004. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P860004

Explore the linked device profile

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic, Inc.

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
7000 Central Ave., NE, Minneapolis, MN, 55432

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records